About One bio
One bio is a Healthcare company based in New York (United States) founded in 2015 by Matt Barnard and Matthew Amicucci. Online tools for partner management and opportunity screening. One bio has raised $27 million across 1 funding round from investors including iSelect, dsm-firmenich and Remy. Its chief executive, as recorded, is Matt Barnard. One bio offers products and services including WholeFibersâ„¢. Its focus areas include HealthTech, Life Sciences Tech, Business Development and Life Sciences. Its competitors include Pendulum, Harmless Harvest and Oragenics; 2 of its 3 listed competitors have raised funding.
Company details
one.bio was founded in 2015 in New York, United States, to support business partnering in the life sciences sector. Tools are offered for recruiting partners and screening opportunities, including the meet.bio platform, which connects companies, individuals, assets, and locations to facilitate interactions. The deals.bio tool is utilized for evaluating biotech and pharmaceutical prospects online. Operations focus on affordable, user-friendly solutions for professionals in this field.
- Total Equity Funding$27M (USD)
in 1 rounds
- Latest Funding Round$27M (USD), Series A
Dec 2024
- InvestorsiSelect
& 8 more
Products & Services of One bio
One bio offers a comprehensive portfolio of products and services, including WholeFibers™.
Integrates active plant fibers into food for gut health benefits.
Funding Insights of One bio
One bio has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series A round of $27 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27M
- Total Rounds 1
- Last Round Series A — $27M
- First Round $27M
(Dec 2024)
- Investors Count 9
All 1 funding rounds of One bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $27M | Series A | – | Alpha Edison |
9 investors in total: 9 institutional.
Investors in One bio
One bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include iSelect, dsm-firmenich and Remy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Series A and growth-stage investments are made by Alpha Edison. | alphaedison.com | Los Angeles, United States | ||
Venture capital firm investing in life sciences sector | leaps.bayer.com | Leverkusen, Germany | ||
E12 Ventures is focused on early-stage technology investments. | e12.ventures | |||
US based VC firm investing in seed stage | moradoventures.com | San Francisco, United States | ||
Micro-venture capital firm investing in pre-seed to seed stage startups | better.vc | Oakland, United States | ||
Venture capital investments are directed toward life science sectors. | skyviewslifescience.com | |||
Audits and regulatory compliance are managed via a cloud-based platform. | 2016 | remy.co | New York, United States | |
Innovative solutions in nutrition, health, and beauty are provided by dsm-firmenich. | 1869 | dsm-firmenich.com | Kaiseraugst, Switzerland | |
Financial products and utilities are compared online by iSelect. | 1999 | iselect.com.au | Cheltenham, Australia |
Investor details for One bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of One bio
3 people are tracked at One bio (3 in leadership).
| Name | Role | Group |
|---|---|---|
Matt Barnard | Co-Founder & Co-CEO | Leadership |
Matthew Amicucci | Co-Founder | Leadership |
Hansruedi Kottmann | Co-CEO | Leadership |
Complete people profiles for One bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of One bio
2 dated milestones of One bio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded One bio is founded.
- Funding First funding round of $27.0M.
Competitors of One bio
One bio has 3 listed competitors in our database, 2 of them funded. They include Pendulum, Harmless Harvest and Oragenics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pendulumlife.com | 2012 | San Francisco, United States | $109.5M | 55 | Pendulum is focused on developing advanced probiotic solutions. | |
| harmlessharvest.com | 2009 | San Francisco, United States | $30M | 47 | Branded coconut water and probiotic beverages are manufactured and marketed. | |
| oragenics.com | 1996 | Tampa, United States | 5 | Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health |
Detailed competitors of One bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of One bio
The website of One bio (one.bio) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 21.1% vs previous month
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as One bio (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about One Bio
Complete news archive for One bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about One bio
One bio was founded in 2015 and raised its 1st funding round 9 years after it was founded.
One bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Matt Barnard is the CEO of One bio, as recorded in our data. They have also founded this company.
One bio is a funded company, having raised a total of $27M across 1 funding round to date. The company's 1st funding round was a Series A of $27M, raised on Dec 2024.
one.bio was founded in 2015 in New York, United States, to support business partnering in the life sciences sector. Tools are offered for recruiting partners and screening opportunities, including the meet.bio platform, which connects companies, individuals, assets, and locations to facilitate interactions. The deals.bio tool is utilized for evaluating biotech and pharmaceutical prospects online. Operations focus on affordable, user-friendly solutions for professionals in this field.
One bio's top competitors include Pendulum, Harmless Harvest and Oragenics.
One bio offers WholeFibersâ„¢.
One bio has 9 investors. Key investors include iSelect, dsm-firmenich, Remy, Alpha Edison, and Leaps by Bayer.